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Abstract 
We found that bone marrow stromal cells (BMSCs) do not survive for long enough to serve 
as a scaffold for regenerating axons after transplantation i  the injured spinal cord of rats. 
However, axonal regeneration was facilitated, possibly by trophic factors secreted from 
transplanted BMSCs. Regenerating axons were not associated with astrocytes, but 
surrounded by Schwann cells (SCs), and embedded in collagen fibril matrices just as the 
axons of peripheral nerves. 
Experiments involving the transplantation of SCs themselves indicated that, besides 
exogenous SCs, intrinsic SCs infiltrated the lesion and formed myelin sheaths on 
regenerating axons in the same manner as described with BMSC transplantation. 
The transplantation of olfactory ensheathing cells (OECs) showed that OECs themselves 
enclosed regenerating axons in the same manner as SCs. No study has been carried out to 
address whether such Schwann-like cells were derived from transplanted OECs or 
intrinsic SCs. However, the possibility cannot be excluded that intrinsic SCs contributed to 
surround regenerating axons. 
Neural stem cells (NSCs) derived from  iPS cells survived long-term, emanating numerous 
axons that extended over a long distance through the host spinal cord tissue. However, no 
myelination occurred on regenerating axons, and no behavioral improvement was 
observed. It would be difficult to manipulate iPS-derived NSCs to appropriately integrate 
them into the host spinal cord tissue. In this respect, iPS cells have crucial problems 
concerning whether they can be integrated appropriately into the host tissue. 
Muse cells (multilineage-differentiating stress-enduring cells) were separated as  SSEA3- 
positive cells from BMSCs. Transplanted Muse cells survived long-term, but they were 
not as effective as non-Muse cells or BMSCs for the treatment of infarcted brains, 
suggesting that trophic factors from non-Muse cells and BMSCs are involved in those 
effects. 
These findings indicate that intrinsic SCs and trophic factors released from transplants 
may play important roles in nerve regeneration of the spinal cord. Differing from the 
generally believed pattern of regeneration, glial cells are not necessarily needed as the 
scaffolds for growing axons in the spinal cord. 
Key words : spinal cord injury, axonal regeneration, bone marrow stromal cell, Schwann 
         cell, olfactory ensheathing cell,  iPS cell, Muse cell
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Introduction
 It was previously believed that there was no 
nerve regeneration in the injured spinal cord. No 
distinct nerve regeneration was reported in 
studies involving experimental spinal cord injuries 
before the early 1980's. However, sciatic nerve 
transplantation into the spinal cord or medulla 
oblongata demonstrated that CNS neurons within 
the spinal cord or medulla oblongata extended 
regenerating axons through the transplanted 
 peripheral nerve segment (David and Aguayo, 
1981). This experiment clearly showed that CNS 
neurons have an ability to produce regenerating 
axons when an appropriate environment is 
provided. 
 Since then, the transplantation of various kinds 
of cell and tissue has been studied in an attempt o 
provide a suitable environment for CNS neurons 
to produce regenerating axons in the spinal cord 
lesion. 
 The premise of cell transplantation studies 
is that transplanted cells should be integrated 
into the host spinal cord tissue to survive long-
term, serving as a scaffold for the extension 
of regenerating axons through the lesion. This 
premise is based on the hypothesis that trans-
planted cells or tissues can replace the injured 
host tissues. However, this is not necessarily the 
case. In our studies, transplanted cells dis-
appeared within 2-3 weeks after transplantation. 
Nevertheless, the locomotor behaviors and tissue 
repair, including cavity formation and axonal 
regeneration, were improved: cavity formation 
was repressed and axonal regeneration was 
promoted. These findings suggested that, 
although they did not survive long enough to 
replace the injured host tissue, transplanted cells 
accelerated tissue recovery, probably due to the 
secretion of certain trophic factors effective for 
tissue repair, including axonal regeneration, in the 
spinal cord.
Transplantation of bone marrow stromal cells
 We have been studying transplantation of bone 
marrow stromal cells (BMSCs) in rat spinal cord 
injuries. Rat bone marrow cells from femurs and 
tibial bones were cultured, and cells that prolife-
rated on the base of the dish were harvested for 
transplantation. BMSCs were transplanted by 
directly injecting them into the injured spinal 
cord, or by infusing into the CSF via the fourth 
ventricle. In either case, the locomotor behaviors 
as evaluated by the BBB score were improved,
and the spinal cord lesion was well repaired, 
resulting in reduced cavity formation. A notable 
finding was that extensive axonal regeneration 
occurred in the spinal cord lesion: regenerating 
axons extended through the space devoid of as-
trocytes in the spinal cord lesion. The astrocyte-
devoid area contained collagen fibril matrices in 
which regenerating axons extended vigorously. 
It was suggested that astrocytes could not invade 
collagen fibril-filled areas. In our studies, trans-
planted cells disappeared from the spinal cord 
regardless of the method of cell transplantation; 
however, extensive nerve regeneration occurred 
through the spinal cord lesion, and behavioral 
functions as estimated by the BBB score were 
improved (Ohta et al., 2004; Ide et al., 2010; 
Nakano et al., 2013). Another notable finding was 
that regenerating axons extended through the 
spinal cord lesion, in which no invasion or pro-
liferation of astrocytes was found (Fig. 1). There 
was no finding indicating that regenerating axons 
were blocked at the border of the lesion (Fig. 2). 
Regenerating axons were surrounded by SCs and 
embedded in collagen fibril matrices (Fig. 3). This 
finding indicated that regenerating axons were 
peripheral nerves. 
 Regenerating axons extended without being 
blocked at the caudal or rostral border of the 
lesion. Although no data were available con-
cerning synaptic connections of regenerating 
axons with host neurons, the prominent loco-
motor recovery suggested that there may be 
effective neural connections between regener-
ating axons and host neurons. It had been 
believed that regenerating axons extended 
through the repaired CNS tissues consisting of 
astrocytes and oligodendrocytes, and that re-
generating axons may extend caudally or 
rostrally through the repaired astrocytic tissues. 
However, such patterns of nerve regeneration 
were not found to be common in spinal cord 
injuries. As described above, regenerating axons 
extended through the collagen fibril matrices as 
peripheral nerves. Basically the same findings of 
axonal regeneration were seen in the spinal cord 
lesion of control rats, although the axonal 
population was much smaller than that of the cell-
transplanted spinal cord. 
 We suggest that this may be a basic and in-
trinsic pattern of axonal regeneration in the spinal 
cord lesion. Our standpoint is that it would be 
optimal for the treatment of spinal cord injury if 
cell transplantation could elicit and enhance the 
"i
ntrinsic properties" of nerve regeneration of the 
spinal cord. In this respect, the generally believed
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 a-1. GFAP-immunohistochemistry of the section from the epicenter of the lesion before transplantation. Sections were 
   stained with FITC-labeled anti-mouse IgG antibody for GFAP. There is a cavity (asterisk) in the center of the spinal 
   cord, and astrocytes (green) surround the cavity. Astrocyte scar is not distinct on the border of the cavity.Scale: 
  200   m 
a-2. Double-staining for GFAP (green) and neurofilaments (red) of the section adjacent o  a-1. The area corresponding 
   to the circle in  a-1 was enlarged. Axons were stained by Cy-3-labeled anti-rabbit IgG antibody. Some axons 
   (arrows) are associated with oligodendrocytes as shown in a-3. 
a-3. Double-staining for GFAP (green) and  GST-   (red) of the section adjacent o  a-1. The area corresponding to the 
   circle in  a-1 was enlarged.  oligodendrocytes were stained by Cy-3-labeled anti-rabbit IgG antibody. Short cell 
   strands of oligodendrocytes (arrows) extend into the cavity, without accompanying astrocyte processes. No distinct 
   astrocyte scar was formed. Scale: 20     (a-2 and 3) 
 b-1. BMSC transplantation. GFP-transgenic BMSCs (green) are located as cell assemblies (long arrows) in the center of 
   the spinal cord. Astrocytes immunostained by Cy-3-labeled antibody (red) are seen in the ventral part of the spinal 
   cord, while the dorsal side (asterisk) of the BMSC assemblies is devoid of GFAP immunoreactivity. Small BMSC 
   clusters (short arrows) are also seen at the periphery of the spinal cord. 
b-2. Immunohistochemistry for neurofilaments of the section adjacent o  b-1. Numerous axons stained by Cy-3-labeled 
   antibody (red) are seen in the astrocyte-devoid area (asterisk) of the spinal cord. 
b-3. Immunohistochemistry for  GST-  of the section adjacent o b-2. No distinct staining for oligodendrocytes i found 
   in the astrocyte-devoid area (asterisk) of the spinal cord. Scale: 500   m  (b-1, 2 and 3) 
 c. Higher magnification of the astrocyte-devoid area of the section obtained from the same series of sections  (b-1, 2, 
   and 3), but at the different level from them. Immunohistochemistry for neurofilaments. Abundant axons (red) are 
   found around engrafted BMSCs (green, arrows) in the astrocyte-devoid area of the spinal cord. Scale: 50   m 
   (From Ide et al., 2010)
Fig. 1 Spinal cord before cell transplantation (2 weeks after crush injury)  (a-1, 2,and 3), and  1 week after BMSC transplantation
 (b-1, 2, 3, and c).
premise that transplanted cells should survive to 
serve as a scaffold for regenerating axons, or as a 
source of neuronal cells to replace the injured host
tissues, might not necessarily be 
spinal cord regeneration studies.
applicable to
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 a-1. HE staining. The lesion is filled with tissues (S) apparently different from spinal cord parenchyma (H). No distinct cavity is formed. 
   An asterisk indicates the site of engrafted BMSCs shown in a-2. 
a-2. The section adjacent o  a-1. Engrafted BMSCs (green) are located as cell assemblies (asterisk) at the border of the lesion shown in  a-1. 
a-3. GFAP immunohistochemistry (red) in the section adjacent to a-2. A large astrocyte-devoid area (S) extends rostro-caudally. 
   Engrafted BMSCs (site indicated by asterisk) are located at the border of astrocyte-devoid area. 
a-4. Immunohistochemistry for neurofilaments in the section adjacent to a-3. It is remarkable that numerous axons (red) extend in 
   bundles along the whole length of the astrocyte-devoid area shown in a-3. These axons appear in continuity with host nerve 
   networks in the transitional zones on the rostral as well as caudal side (arrows). Asterisk indicates the site of engrafted BMSCs 
   shown in a-2. H: spinal cord  parenchyma. Scale: 2 mm  (a-1, 2, 3 and 4) 
 b-1. Magnification of the part marked with a circle in a-2, showing the relationship between engrafted BMSCs (green) and astrocytes 
   (red, GFAP immunohistochemistry). Most BMSCs extend longitudinally, and are only partly in association with astrocytes. 
b-2. Magnification of the part marked with a triangle in a-2, showing the relationship between engrafted BMSCs (green) and axons (red, 
   neurofilament immunohistochemistry). Regenerating axons are in intimate association with engrafted BMSCs. 
b-3. Magnification of regenerating axons marked with a circle in a-4. Axons extend longitudinally through the astrocyte-devoid  area. 
   Scale: 50  m  (b-1, 2, and 3) 
 c-1. Control (vehicle injection). Horizontal section. HE staining. There are cavities (asterisks) and a tissue area  (S) different from the host 
   spinal cord tissue in the lesion. 
c-2. The section adjacent o  c-1. GFAP staining. Astrocytes are found around cavities (asterisks). 
c-3. The section adjacent to c-2. Neurofilament staining. Some axons (red) remain around cavities (asterisks)  ; however, few axons are 
   found in the lesion  (S). Scale: 2 mm  (c-1, 2 and 3) 
   (From Ide et al., 2010)
Fig. 2 One week after transplantation. Horizontal sections. Left to right: rostro-caudal direction. These micrographs show that 
regenerating axons extend longitudinally through the astrocyte-devoid  area
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a. Epon section. A cell assembly (asterisk) presumed as engrafted  BMSCs is located in the white matter of the 
 spinal cord. The border of host white matter containing degenerated  myelin sheaths is marked by a dotted line. 
 The dorsal part (double asterisks) of the cell assembly is lacking in the host white matter, corresponding to the 
 astrocyte-devoid area seen in Fig. lb. Scale : 50   m. 
b. Electron micrograph taken from the area dorsal to the cell assembly in  "a". There are numerous  unmyelinated 
 axons (some are labeled  "  A  ") covered by cell processes (arrows) or a cell body  (S), suggesting that these axon-
 associated cells might  be Schwann cells. These  unmyelinated axons correspond to the abundantaxons 
 demonstrated by  immunohistochemistry in Fig. lb-2 and c, and Fig. 2a-4 and b-2 and 3. Scale:  2  m 
 c-1. Magnification of an unmyelinated axon bundle. Two axons (A) are surrounded by cell processes  (S) with 
   basal  laminae (arrows) on their surface. This feature indicates growing axons surrounded by immature 
   Schwann cell processes. Collagen fibrils (Co) are seen around the nerve bundle. Scale: 500 nm 
c-2. This micrograph shows that an immature Schwann cell  (S) covered by basal lamina (arrows) surrounds 
   unmyelinated axons (A). Scale: 1  m 
   (From Ide et al., 2010)
 Fig. 3 Conventional electron  microscopy.
Transplantation of Schwann 
tory ensheathing cells
cells and  olfac-
 On the other hand, the transplantation of SCs 
and olfactory ensheathing cells (OECs) has been 
extensively studied for the treatment of spinal 
cord injuries. 
 SCs are associated with axons of peripheral 
nerves, and form a myelin sheath on thick axons of 
more than  1   m in diameter. Transplantation of 
peripheral nerve segments provides an appro-
priate environment for axonal regeneration in the 
CNS, as demonstrated by David and Aguayo 
(1981). This indicates that SCs serve as an effec-
tive conduit for regenerating axons in the CNS. 
Since this study, the transplantation of cultured 
SCs has been extensively studied for the treat-
One week after  transplantation.
ment of spinal cord injury. These studies are 
based on the hypothesis that transplanted SCs 
survive long-term in the spinal cord lesion, serving 
as a scaffold for growing axons. However, the 
report by Hill et al. (2006) showed that trans-
planted SCs disappeared from the spinal cord 
shortly after transplantation, followed by the 
infiltration of intrinsic (endogenous) SCs (P75 + 
cells) into the lesion. This study showed that the 
transplantation of exogenous SCs induces the 
proliferation of intrinsic SCs, which may play an 
important role in spinal cord repair. The ap-
pearance of intrinsic SCs after cell transplantation 
is the same as that with BMSC transplantation. A 
certain fraction of transplanted exogenous SCs 
survived by immunosuppression with cyclo-
sporine.
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 OECs surround axons of the olfactory nerve, 
extending from the olfactory mucosa to olfactory 
bulb. They are unique in that they have dual 
properties characteristic of astrocytes and SCs at 
the same time. They are considered, owing to 
these characteristics, to be able to contribute to 
axonal regeneration in the spinal cord lesion: as 
SCs, they serve as a conduit for regenerating 
axons, and as astrocytes they assist regenerating 
axons to enter the host spinal cord tissue. In his 
transplantation study, Raisman (2007) reported 
that regenerating nerves entered the OEC graft, 
and traversed the lesion to re-enter the host spinal 
cord. Axons were ensheathed by Schwann-like 
cells and enclosed in a perineurial-like sheath of 
fibroblasts in the OEC graft. These axons became 
myelinated by Schwann-like cells during the 
course through the OEC graft, and by oligo-
dendrocytes after re-entering the host spinal cord. 
This description suggested that the engrafted 
OECs served as a scaffold for the growth of 
regenerating axons, and that engrafted cells 
might differentiate into Schwann-like cells and/or 
perineurial cells. 
 OECs are closely associated with astrocytes, 
suppressing astrocytic glial formation at the 
lesion. This effect opens a door for regenerating 
axons to enter the host spinal cord tissue beyond 
the lesion borders. Since OECs were not labeled 
before transplantation, their fates could not be 
precisely determined in the spinal cord lesion. 
 On the other hand, Torres-Wspin and col-
leagues (Torres-Wspin et al., 2014) reported that 
OECs survived until 7 days after transplantation, 
but disappeared in the following 2 weeks. Even 
though they did not survive for a long time, tissue 
protection occurred in the lesion. These findings 
indicate that OECs are similar to BMSCs in their 
fates after transplantation. As far as OECs  ob-
tained from rats are concerned, the lifespan may 
be as short as that of BMSCs. Based on this 
hypothesis, it is probable that OECs did not serve 
as a scaffold for regenerating axons. Schwann-
like cells and perineurial-like cells observed in the 
OEC grafts may not be derived from engrafted 
OECs, but, instead, derived from the host tissue as 
suggested in BMSC transplantation.
Transplantation of iPS-derived neural stem 
cells
 Since the introduction of iPS cells, it has been 
anticipated that the transplantation of iPS-
derived NSCs might be efficient for spinal cord 
injury. It has been suggested that engrafted
NSCs differentiate into neural cells including, 
neurons, astrocytes, and oligodendrocytes to 
replace the injured tissues, and that neurons 
derived from iPS cells regenerate axons to re-
establish neural connections in the host spinal 
cord tissue. However, there was previously no 
report concerning the effects of iPS-derived cell 
transplantation on the spinal cord injury. 
 The recent study by Lu and colleagues (Lu et 
al., 2015) reported findings on the transplantation 
of iPS-derived NSCs into the spinal cord injury. 
Human iPS cells were obtained from dermal 
fibroblasts of a healthy 86-year-old male and 
driven toward a NSC lineage. NSCs were labeled 
with GFP using a lenti-viral vector. GFP-ex-
pressing NSCs were embedded in fibril matrices 
containing a growth factor cocktail to promote 
graft survival and retention in the lesion site. 
Cells were transplanted into a C5 spinal cord 
hemisection lesion site 2 weeks after the original 
spinal cord injury. Rats underwent weekly func-
tional assessments and were sacrificed 3 months 
after transplantation. The results were as fol-
lows: iPS-derived NSCs survived and differen-
tiated into neurons and glia, and extended tens of 
thousands of axons from the lesion site over 
virtually the entire length of the rat CNS. These 
iPS-derived axons extended through the space 
between myelinated axons of white matter of the 
injured spinal cord, frequently penetrating gray 
matter and forming synapses with host neurons. 
No myelination occurred on such axons. There 
was no improvement of behavioral functions. 
 This study suggests that iPS-derived NSCs 
have many serious problems with clinical appli-
cations, as follows: 
 1. It is difficult to control the production of re-
    generating axons from the engrafted NSCs. 
    The number of axons appeared to be several 
    times larger than that in the normalwhite 
    matter. It is desirable for regenerating 
    axons with no synapses to be eliminated 
    (spliced) in due course. 
 2. Although some synaptic connections ap-
    peared to be formed between regenerating 
    axons and host neurons, such neural con-
    nections showed no influence on locomotor 
    functions. 
 3. Regenerating axons should be myelinated 
    for normal functioning. 
 4. The most disappointing finding was that 
    there was no behavioral recovery 3 months 
    after transplantation in rats.
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Transplantation of Muse cells proved in due course.
 Muse cells were identified and separated from 
mesenchymal cells (Kuroda et al., 2010). At 
present, Muse cells are isolated from BMSCs as 
stage-specific embryonic antigen 3 (SSEA-3)-posi-
tive cells. So far, no study has been reported 
concerning the effect of Muse cells on spinal cord 
injury. The recent study by Yamauchi and 
colleagues (Yamauchi et al., 2015) deals with the 
effects of Muse cells on the functional recovery of 
rats with ischemic stroke. Muse and non-Muse 
cells were separated from human BMSCs, and 
both were labeled with GFP using a lenti-viral 
vector. On the other hand, immunodeficient mice 
were subjected to permanent middle cerebral 
artery occlusion to induce an ischemic lesion in 
the brain. GFP-expressing Muse and non-Muse 
cells were transplanted into the ipsi-lateral 
striatum of mice with infarction 7 days later. 
Muse cell-transplanted mice exhibited no func-
tional recovery for up to 4 weeks, but a slight 
improvement at 5 weeks after transplantation. 
Non-Muse cell-transplanted mice displayed more 
effective recoveries than mice transplanted with 
Muse cells. In parallel, they performed the trans-
plantation of BMSCs in the same manner. BMSC-
transplanted mice showed the most favorable 
recovery of behavioral functions. Muse cells sur-
vived in the brain tissue longer-term compared 
with non-Muse cells or BMSCs. This report 
explains the results as follows: non-Muse cells and 
BMSCs did not replace the injured tissue, but had 
influences by secreting trophic effects. On the 
other hand, Muse cells were integrated into the 
 peri-infarct cortex, and spontaneously differen-
tiated into neuronal cells to replace lost neurons. 
No data were available concerning axonal pro-
duction from integrated Muse cells in this report. 
If Muse cell-derived neurons produce axons, 
contributing to neural connections in the brain, it 
is expected that locomotor behaviors will be im-
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